The paradoxical patent ductus arteriosus

Journal of Clinical Investigation

Volumn 116, Issue 11, 2006, Pages 2863-2866

  Ivey, Kathryn N ^a   Srivastava, Deepak ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

CYTOCHROME C OXIDASE DEFICIENCY; DUCTUS ARTERIOSUS; NONHUMAN; PATENT DUCTUS ARTERIOSUS; PERINATAL PERIOD; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE; VASODILATATION;

ANIMALS; DUCTUS ARTERIOSUS; ENZYME INHIBITORS; HUMANS; RECEPTORS, PROSTAGLANDIN E; SIGNAL TRANSDUCTION;

EID: 33750579016     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI30349     Document Type: Review

References (15)

1. Smith, G.C. 1998. The pharmacology of the ductus arteriosus. Pharmacol. Rev. 50:35-58.
2. Gittenberger-de Groot, A.C. 1977. Morphology of the normal human ductus arteriosus. In The ductus arteriosus, report of the 75th Ross Conference on Pediatric Research. M.A. Heymann and A.M. Rudolph, editors. Ross Laboratories. Columbus, Ohio, USA. 3-9.
3. Hoffman, J.I., and Kaplan, S. 2002. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 39:1890-1900.
4. Heymann, M.A., Rudolph, A.M., and Silverman, N.H. 1976. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N. Engl. J. Med. 295:530-533.
5. Friedman, W.F., Hirschklau, M.J., Printz, M.P., Pitlick, P.T., and Kirkpatrick, S.E. 1976. Pharmacologic closure of patent ductus arteriosus in the premature infant. N. Engl. J. Med. 295:526-529.
6. Nguyen, M., et al. 1997. The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature. 390:78-81.
7. Loftin, C.D., et al. 2001. Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. Proc. Natl. Acad. Sci. U. S. A. 98:1059-1064.
8. Yokoyama, U., et al. 2006. Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus. J. Clin. Invest. 116:3026-3034. doi:10.1172/JCI28639.
9. Morano, I., et al. 2000. Smooth-muscle contraction without smooth-muscle myosin. Nat. Cell Biol. 2:371-375.
10. Reese, J., Anderson, J.D., Brown, N., Roman, C., and Clyman, R.I. 2006. Inhibition of cyclooxygenase isoforms in late- but not mid-gestation decreases contractility of the ductus arteriosus and prevents postnatal closure in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. doi:10.1152/ajpregu.00259.2006.
11. Norton, M.E., Merrill, J., Cooper, B.A., Kuller, J.A., and Clyman, R.I. 1993. Neonatal complications after the administration of indomethacin for pre-term labor. N. Engl. J. Med. 329:1602-1607.
12. Hammerman, C., et al. 1998. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity. Pediatrics. 102:E56.
13. Tada, T., and Kishimoto, H. 1990. Ultrastructural and histological studies on closure of the mouse ductus arteriosus. Acta Anat. (Basel). 139:326-334.
14. Gentile, R., et al. 1981. Pulsed Doppler echocardiographic determination of time of ductal closure in normal newborn infants. J. Pediatr. 98:443-448.
15. Bergwerff, M., DeRuiter, M.C., and Gittenberger-de Groot, A.C. 1999. Comparative anatomy and ontogeny of the ductus arteriosus, a vascular outsider. Anat. Embryol. (Berl.). 200:559-571.